Educational Videos to Improve Patient Decision Making and Race Disparities in Implantable Cardioverter Defibrillator Use
| Status: | Completed |
|---|---|
| Conditions: | Cardiology |
| Therapuetic Areas: | Cardiology / Vascular Diseases |
| Healthy: | No |
| Age Range: | 19 - Any |
| Updated: | 4/21/2016 |
| Start Date: | November 2010 |
| End Date: | April 2012 |
The Use of Educational Videos to Improve Patient Decision Making and Racial Disparities in the Implantation of Implantable Cardioverter Defibrillators (ICDs)
The investigators will examine whether an educational video increases patient knowledge
about heart failure and the risk of sudden cardiac arrest and leads to greater satisfaction
with information provided as compared to usual care. Additionally, the investigators will
look at whether racial concordance (physician and patient being of the same race) improves
satisfaction with the patient's treatment decision and disease knowledge. Our hypothesis is
that a video in which participants are of the same race as the patient will provide better
education and more satisfaction with the treatment decision and may lead to more patients
choosing ICD therapy.
about heart failure and the risk of sudden cardiac arrest and leads to greater satisfaction
with information provided as compared to usual care. Additionally, the investigators will
look at whether racial concordance (physician and patient being of the same race) improves
satisfaction with the patient's treatment decision and disease knowledge. Our hypothesis is
that a video in which participants are of the same race as the patient will provide better
education and more satisfaction with the treatment decision and may lead to more patients
choosing ICD therapy.
Inclusion Criteria:
- Class I primary prevention indications for an implantable cardioverter defibrillator
(ICD). These include:
- Patients with ejection fraction <35% due to prior myocardial infarction (MI) who are
at least 40 days post-MI and with New York Heart Association (NYHA) functional class
II or III;OR
- Patients with nonischemic dilated cardiomyopathy (DCM) who have an LVEF < 35% and who
meet criteria for NYHA functional class II or III; OR
- Patients with left ventricular dysfunction due to prior MI who are at least 40 days
post-MI, have an left ventricular ejection fraction (LVEF) <30% and are in NYHA
functional class I-III; OR
- Patients with nonsustained ventricular tachycardia (VT) due to prior MI, LVEF <40%,
and with inducible ventricular fibrillation (VF) or sustained VT at
electrophysiological study; AND
- Self identified race as black/African American or white/Caucasian
We found this trial at
2
sites
Duke Univ Med Ctr As a world-class academic and health care system, Duke Medicine strives...
Click here to add this to my saved trials
Click here to add this to my saved trials